ADA guidelines ‘a positive step’ towards coverage, says Wells Fargo

Wells Fargo notes that on Monday, American Diabetes Association published its 2025 Standards of Care in Diabetes guidelines, which includes a new recommendation for CGM use in people with T2 diabetes, including those not on insulin. The choice of device should be made based on the individual’s circumstances, preferences, and needs, it said. The firm views this as a positive step forward toward coverage. Publicly traded companies in the space include Abbott (ABT) and Dexcom (DXCM).